Inizio Biotech announces MassBio Membership

Inizio Biotech, a business unit of Inizio, and a single source for best-in-class biotech services from clinical development to commercialization has become a member of the non-profit organization, MassBio. 

Inizio Biotech is a strategic partner that supports emerging biotech companies  in their journey from clinical development to commercialization, offering scalable solutions to guide, validate, and inspire the decisions that will maximize asset value.  

Founded in 1985, MassBio currently represents 1,400+ members in the life science and healthcare industry. All members share a united vision to improve patient lives by preventing, treating and curing life-threatening illnesses through new transformative technology.

The organization was established to advance the healthcare sector by providing a platform for like-minded professionals to educate and support each other. Through a series of networking events, conferences and training courses, MassBio provides a forum for biotechs to connect with global life science leaders and have access to expertise that will further their clinical development journey.

Jason McKenna, Global President at Inizio Biotech, commented “Emerging biotech are increasingly looking to us for the specific expertise and tailored solutions that help maximize the value of their assets throughout the product lifecycle.  Our partnership with MassBio will provide a platform to collaborate and share the knowledge and expertise found across Inizio to achieve better patient and business outcomes.”

Inizio Biotech provides a wide range of services including:

• Clinical development strategy 
• Medical affairs
• Commercial strategy 
• Evidence, pricing, and access
• Brand and creative development
• Healthcare provider, patient, and payer engagement

Find out more about Inizio Biotech and its services across phase I to phase III here. 

Or if you’d like to get in touch with one of our consultants about your biotech service needs, please see here.